The Enterprise Value as of March 2026 (TTM) for Revolution Medicines, Inc. (RVMD) is 18.57B

According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.57B. This represents a change of 101.87% compared to the average of 9.20B of the last 4 quarters.

Revolution Medicines, Inc. (RVMD) Historical Enterprise Value (quarterly & annually)

How has RVMD Enterprise Value performed in the past?

The mean historical Enterprise Value of Revolution Medicines, Inc. over the last ten years is 3.75B. The current 18.57B Enterprise Value has changed 49.46% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Enterprise Value was at its highest in in the December 2025 quarter at 14.92B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Revolution Medicines, Inc. (RVMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revolution Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revolution Medicines, Inc. (RVMD) Average Enterprise Value

How has RVMD Enterprise Value performed in the past?

The current Enterprise Value of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revolution Medicines, Inc. (RVMD) Enterprise Value vs. Peers

How is RVMD’s Enterprise Value compared to its peers?

Revolution Medicines, Inc.’s Enterprise Value is greater than BridgeBio Pharma, Inc. (15.61B), greater than Ionis Pharmaceuticals, Inc. (14.00B), greater than Exelixis, Inc. (10.75B), less than Moderna, Inc. (20.08B), greater than BioMarin Pharmaceutical Inc. (10.58B), greater than Summit Therapeutics Inc. (11.79B), greater than Ascendis Pharma A/S (12.38B), less than Roivant Sciences Ltd. (18.81B), greater than Avidity Biosciences, Inc. (1.85B), greater than Madrigal Pharmaceuticals, Inc. (10.26B),

Build a custom stock screener for Revolution Medicines, Inc. (RVMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revolution Medicines, Inc. (RVMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.